HA6968 Glycyrrhetinic Acid Powder (CAS No. 471-53-4)

About This Item

Catalog No.
HA6968
Parameter Value
Material Glycyrrhetinic Acid
CAS Number 471-53-4
Molecular Formula C30H46O4
Purity ≥97% (HPLC)
Appearance White Powder

Related Products: Ammonium Iron (III) CitrateDeglycyrrhizinated Licorice Powder (DGL)Astaxanthin PowderBeta-carotene (10%) Powder

Quantity

kg

Technical Service

Need help? Our team of experienced scientists is here for you.

Description

Glycyrrhetinic Acid Powder Technical Profile Description

Glycyrrhetinic Acid (C₃₀H₄₆O₄; CAS: 471-53-4) is a high-purity triterpenoid compound obtained through the hydrolysis of glycyrrhizin from Glycyrrhiza glabra. This bioactive molecule features a unique pentacyclic oleanane structure that confers exceptional pharmacological properties.

Key Specifications

Parameter Specification
Appearance Fine crystalline powder
Color White to pale yellow
Odor Odorless
Taste Characteristic bitter
Melting Point 297-302°C
Solubility Soluble in organic solvents
  Sparingly soluble in water
Purity ≥98% (HPLC)

 

Physicochemical Properties

  • Molecular Weight: 470.68 g/mol
  • UV Absorption: λmax 250 nm
  • IR Spectrum: Characteristic peaks at 1700 cm⁻¹ (C=O) and 3400 cm⁻¹ (O-H)
  • Stability: Stable at room temperature; light-sensitive

Mechanism of Action

The compound exerts its biological effects primarily through:

  • Potent inhibition of 11β-HSD enzymes (IC₅₀ = 50-100 nM)
  • Modulation of glucocorticoid receptor activity
  • Antioxidant and anti-inflammatory properties

Industrial Applications

  1. Pharmaceutical Development
Application Concentration Benefit
Anti-inflammatory 5-20 mg/dose Targets rheumatoid arthritis
Hepatoprotective 10-50 mg/dose Reduces chemotherapy toxicity
Oncology Nanoformulated Enhances drug delivery

 

  1. Cosmetic Formulations
Product Type Function Effective Range
Anti-aging serums UV protection & collagen boost 0.1-0.5%
Acne treatments Antibacterial action 0.5-2%
Brightening creams Tyrosinase inhibition 0.2-1%

 

  1. Advanced Research
  • Reference standard for analytical methods
  • Radiation protection studies
  • Transdermal delivery systems development


Quality Assurance

  • Purity Testing: HPLC, GC-MS
  • Contaminant Screening: Heavy metals, residual solvents
  • Certifications: ISO 9001, GMP compliant

Glycyrrhetinic Acid Powder Packaging

Our products are packaged in customized cartons of various sizes based on the material dimensions. Small items are securely packed in PP boxes, while larger items are placed in custom wooden crates. We ensure strict adherence to packaging customization and the use of appropriate cushioning materials to provide optimal protection during transportation.

Glycyrrhetinic Acid Powder FAQs

Q1. What is glycyrrhetinic acid?

Glycyrrhetinic acid is a bioactive triterpenoid compound derived from licorice root (Glycyrrhiza glabra), formed by the hydrolysis of glycyrrhizin. It exists as a pale-yellow to white crystalline powder and serves as the core aglycone responsible for licorice’s pharmacological effects.

Q2. What are its key properties?

This compound exhibits potent anti-inflammatory, antiviral (notably against herpesviruses), and hepatoprotective activities. It achieves these effects primarily by inhibiting 11β-hydroxysteroid dehydrogenase (11β-HSD), modulating cortisol metabolism. Unlike corticosteroids, it lacks immunosuppressive side effects at therapeutic doses.

Q3. What are its main applications?

Glycyrrhetinic acid is widely used in dermatology for treating eczema, psoriasis, and acne due to its ability to reduce inflammation and promote skin repair. It’s also formulated in oral care products for gingivitis, studied for liver protection against toxins, and applied in antiviral therapies targeting hepatitis and herpes simplex viruses.

Reviews

5 Stars
2
4 Stars
0
3 Stars
0
2 Stars
0
1 Stars
0
Write a review

Get a Quote

Send us an inquiry now to find out more information and the latest prices, thanks!
Product Name
Quantity
Name
Email
Phone
Company
Application
Country
United States
  • United States
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos (Keeling) Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Democratic Republic of Congo
  • Denmark
  • Disputed Territory
  • Djibouti
  • Dominica
  • Dominican Republic
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Federated States of Micronesia
  • Fiji
  • Finland
  • France
  • French Guyana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Iraq-Saudi Arabia Neutral Zone
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands Antilles
  • Netherlands
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • North Korea
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestinian Territories
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Helena and Dependencies
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and South Sandwich Islands
  • South Korea
  • Spain
  • Spratly Islands
  • Sri Lanka
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks And Caicos Islands
  • Tuvalu
  • US Virgin Islands
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
Comments
I would like to join the mailing list to receive updates from Stanford Chemicals.
Check Code